Eversense ® 365 approved and launched in the U.S. during 2024 as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes Patient base increased 56% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback